drugset / Trial / NCT01433471

Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova

NCT01433471 ↗

Completed 4 enrolled NYU Langone Health
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to understand the immune response activated in the human gastrointestinal tract by Trichuris Suis Ova (TSO) in patients with ulcerative colitis.

Timeline

Start
2012-08
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Trichuris suis ova Other / unclassified 2500 unknown Oral

Indications